Principia Biopharma Appoints Roy Hardiman As Chief Business Officer And Lewis Shuster To Board Of Directors

Principia Biopharma Inc., a private, clinical-stage biopharmaceutical company, today announced that Roy Hardiman has been appointed to the newly created position of Chief Business Officer and Lewis “Lew” Shuster has been appointed to the company’s board of directors.

Help employers find you! Check out all the jobs and post your resume.

Back to news